Bergsten Goran, Samuelsson Martin, Wullt Bjorn, Leijonhufvud Irene, Fischer Hans, Svanborg Catharina
Department of Microbiology, Institute of Laboratory Medicine, Lund University, Lund, Sweden.
J Infect Dis. 2004 May 1;189(9):1734-42. doi: 10.1086/383278. Epub 2004 Apr 14.
Mucosal pathogens differ from normal flora constituents in that they provoke a host response that upsets mucosal integrity. We investigated whether the elaboration of discrete adherence factors is sufficient to break the inertia of the mucosal barrier. PapG-mediated adherence was selected as an example, because P fimbrial expression characterizes uropathogenic Escherichia coli and because adherence starts the attack on the mucosal barrier. Patients were inoculated intravesically with transformed nonvirulent E. coli strains expressing functional P fimbriae (E. coli pap(+)) or mutant fimbriae lacking the adhesin (E. coli Delta papG). E. coli pap(+) was shown to activate the innate host response, and adherent gfp(+) bacteria were observed on excreted uroepithelial cells. E. coli Delta papG failed to trigger a response and was nonadhesive. We conclude that PapG-mediated adherence breaks mucosal inertia in the human urinary tract by triggering innate immunity and propose that this activation step differentiates asymptomatic carriage from infection.
黏膜病原体与正常菌群成分的不同之处在于,它们会引发破坏黏膜完整性的宿主反应。我们研究了特定黏附因子的产生是否足以打破黏膜屏障的惰性。以PapG介导的黏附为例进行研究,因为菌毛表达是致病性大肠杆菌的特征,且黏附是对黏膜屏障攻击的起始步骤。患者经膀胱接种表达功能性菌毛的转化无毒大肠杆菌菌株(大肠杆菌pap(+))或缺乏黏附素的突变菌毛(大肠杆菌ΔpapG)。结果显示,大肠杆菌pap(+)激活了宿主固有免疫反应,且在排出的尿路上皮细胞上观察到了黏附的绿色荧光蛋白(gfp)阳性细菌。大肠杆菌ΔpapG未能引发反应且无黏附性。我们得出结论,PapG介导的黏附通过触发固有免疫打破了人类泌尿道的黏膜惰性,并提出这一激活步骤区分了无症状携带与感染。